Skip to main navigation

About

Who We Are

Management Team
Board of Directors
Program Partners

Pipeline

Cardiovascular
Oncology
Respiratory
Ophthalmology
Inflammatory Disease

Patients

Investors

News & Events

News Releases
Events
Presentations

Stock

Stock Quote & Chart
Analyst Coverage

Governance

Documents & Charters
Management Team
Board of Directors
Committee Composition

Financials

SEC Filings

IR Resources

Investor FAQs
Email Alerts
Contact IR

Contact

English
Chinese, Simplified

News Releases

Year

June 2, 2022

LianBio to Participate in June Investor Events

May 12, 2022

LianBio Reports First Quarter 2022 Financial Results and Provides Corporate Update

May 9, 2022

LianBio Completes Phase 1 Pharmacokinetic Study of Mavacamten in Healthy Chinese Volunteers

May 5, 2022

LianBio to Participate in the Bank of America Securities 2022 Healthcare Conference

May 3, 2022

LianBio Partner Tarsus Pharmaceuticals Announces Positive Topline Data from Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis

April 29, 2022

U.S. Food and Drug Administration Approves Camzyos (mavacamten) for the Treatment of Adults with Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and Symptoms

April 14, 2022

LianBio Announces Formation of Scientific Advisory Board

April 7, 2022

LianBio’s Partner ReViral Enters into Acquisition Agreement with Pfizer

April 7, 2022

LianBio Appoints Wei Wei Chen to Board of Directors

March 30, 2022

LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 13

Print Page

Email Alerts

RSS Feeds

Contact IR

Connect with us on social media.

About

Who We Are Management Team Board of Directors Program Partners

Pipeline Cardiovascular Oncology Respiratory Ophthalmology Inflammatory Disease

Patients

Investors News & Events Stock Governance Financials IR Resources

Contact

© 2022 LianBio. All Rights Reserved.